Infectious Diseases Pharmacy Residency

The University of Kansas Health System is a teaching hospital providing the unique capability to engage pharmacy residents in direct patient care activities, research, administration leadership, project management and teaching skills. Residents carry out the health system’s mission, which is to deliver world-class patient care to the people we serve and ensure the excellence of future patient care through exceptional learning, teaching and research.

Specifically, the postgraduate year 2 (PGY2) infectious diseases pharmacy residency program at the health system provides residents with the skills and knowledge to practice as an infectious diseases clinical pharmacist with formalized training in antimicrobial stewardship. The residency program is designed to transition postgraduate year 1 (PGY1) residency graduates from generalist practice to specialized practice, focused on the care of patients with complex infectious diseases in numerous settings. Antimicrobial stewardship is a secondary focus of the residency, with an emphasis on population management strategies throughout a large health system. After successfully completing the program, graduates will be prepared to sit for the board of certification exam in infectious diseases.

The PGY2 infectious diseases residency program is designed to provide residents with robust experience in the clinical management of patients with infectious diseases as well as population level management through antimicrobial stewardship. We work closely with the infectious diseases physicians and fellows covering 10 consult services that manage a diverse patient population, including patients with cystic fibrosis, human immunodeficiency virus, hematologic and oncologic malignancies, and solid organ and blood and marrow transplants.

For more information on the infectious diseases division within the School of Medicine, faculty, research, and fellowship program, please visit the University of Kansas Medical Center.

The PGY2 pharmacy resident will have the opportunity to actively participate in educational opportunities offered through the infectious diseases fellowship program and the University of Kansas School of Pharmacy. Formal longitudinal responsibilities include participation in the antimicrobial stewardship program, inpatient pharmacy staffing and research. Completion of this program will prepare the resident for a career in clinical infectious diseases practice and antimicrobial stewardship.

• Length of program: 12 months (approximately July-June)
• Number of positions: 1

• Annual salary: $56,000
• Benefits include PTO, paid holidays, health/dental/life/liability insurance
• View more information

The PGY2 infectious diseases residency at The University of Kansas Health System is tailored to the interests and the career goals of each resident. The residency year is organized into both rotational and longitudinal experiences as further described below.

Required learning experiences

• Orientation
• Infectious diseases consultation services (4 total)
• General (2 total)
• Immunocompromised hosts (1 total)
• Advanced general with precepting (1 total)
• Clinical microbiology laboratory
• Antimicrobial stewardship, clinical
• Antimicrobial stewardship, program administration

Elective learning experiences

• Medical intensive care unit
• Hematology/oncology
• Blood and marrow transplantation
• Human immunodeficiency virus clinic
• Outpatient infectious diseases clinic
• Internal medicine

Longitudinal learning experiences

• Inpatient pharmacy departmental service
• The resident will work the equivalent of every fourth weekend (Saturday and Sunday) and holidays as assigned.
• Antimicrobial stewardship
• Contributions to the antimicrobial stewardship program (ASP) may include the following and are not limited to:
• Attendance at ASP meetings
• Completion of a longitudinal ASP-related project
• Presentations in the form of Department of Pharmacy Grand Rounds and Division of Infectious Diseases Journal Club
• Research
• Completion of a research project that enhances personal and professional growth while benefiting the pharmacy department through innovative changes in the way pharmacy is practiced.
• Goals include presenting the results at a conference and familiarizing the resident with the process for submission of original research for publication in a peer-reviewed pharmaceutical or medical journal.

There are many opportunities to customize the program to fit the resident’s individual interests through elective learning experiences. Additional rotations may be developed in addition to those listed here. Please contact the RPD for additional information.

PGY2 Infectious Diseases Manual (Supplement)

Informational sessions

• See social media for links and dates
• Instagram: @tukhspharmres
• Facebook: @tukhspharmres
• LinkedIn

PhORCAS

Deadlines

• Application deadline: Refer to ASHP website
• Licensure:
• Residents are expected to apply for licensure in the state of Kansas as soon as possible following the match
• The health system requires that PGY2 residents are licensed within 60 days of the start of residency.

Checklist for application

• Letter of intent
• Topics to consider: The reason(s) you desire to pursue this infectious diseases residency, your reasons for interest in the PGY2 infectious diseases program at the health system, and personal goals you feel the program would help you accomplish.
• Curriculum vitae
• College transcripts
• 3 letters of recommendation
• PhORCAS residency program application
• ASHP resident matching program registration

National matching services (NMS) code: 619955

We are an equal employment opportunity employer without regard to a person’s race, color, religion, sex (including pregnancy, gender identity and sexual orientation), national origin, ancestry, age (40 or older), disability, veteran status or genetic information.